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Abstract
Changes in genomic DNA caused by exposure to the cytotoxic alkylating agent, 2,2P-dichlorodiethyl sulfide (sulfur
mustard; HD), alone or in combination with selective inhibitors of poly(ADP-ribose) polymerase (PARP), were analyzed as
a function of HD concentration and post-exposure time. Preparations of human peripheral blood lymphocytes were exposed
to HD (1U1038 M^1U1033 M), and incubated at 37‡C for 0^24 h. Total genomic DNA was extracted from these cells and
compared with DNA from control cells of the same donor using agarose gel electrophoresis. The effects of HD on genomic
DNA depended on the HD concentration and the length of the post-exposure time interval. DNA fragmentation was
detected as early as 2 h after exposure to 3U1034 M HD, or at 24 h after exposure to 6U1036 M HD. The qualitative DNA
pattern, as well as the extent of DNA fragmentation, changed with post-exposure time. Exposure to HD caused a time-
dependent shift in the DNA cleavage pattern from an oligonucleosome-sized ‘DNA ladder’ characteristic of apoptotic cell
death, to a ‘broad band’ pattern characteristic of necrotic cell death. DNA fragmentation was not observed if cells were killed
with heat or with Lewisite. Treatment of cells with selective PARP inhibitors consistently altered the DNA fragmentation
caused by HD exposure. The inhibitors arrested DNA fragmentation at the DNA ladder stage. This effect only was observed
if the PARP inhibitors were applied within 8 h of HD exposure. We conclude that early inhibition of PARP activity can
induce a switch in the mechanism of cell death caused by HD. Such a switch may be useful therapeutically to convert a lytic,
pro-inflammatory cell death that includes the disintegration of dying cells (necrosis), into a slower, programmed cell death
that includes absorption of dying cells (apoptosis). 0167-4889 / 98 / $ ^ see front matter ß 1998 Published by Elsevier
Science B.V. All rights reserved.
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1. Introduction
The alkylating agent, 2,2P-dichlorodiethyl sul¢de
(sulfur mustard; HD), is a potent vesicant, or ‘blister
agent’ that causes severe lesions of exposed skin,
lungs, or eyes (reviewed in [1]). There is, to date,
no e¡ective antidote. Herriott and Price implicated
DNA as an important target in the cellular e¡ects of
HD during the late 1940s by demonstrating that bac-
terial viruses were inhibited by mustard gas [2]. These
¢ndings were later extended to mammalian cells [3].
Berger and colleagues [4] proposed a general hypoth-
esis for the mechanism of cell death caused by alky-
lating agents: (1) DNA strand breaks occur as a
direct result of alkylation; (2) poly(ADP-ribose)
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polymerase (PARP; EC 2.4.2.30) is activated by
DNA breaks to synthesize large homopolymers of
ADP-ribose, thereby depleting cellular NAD levels;
and (3) reduced NAD inhibits glycolysis and causes a
loss of the ATP required to maintain normal cellular
metabolism. Papirmeister applied this hypothesis to
explain the cytotoxicity and vesication caused by HD
exposure [5].
Our goal has been to test the Berger/Papirmeister
hypothesis for HD-initiated toxicity using in vitro
models. HD exposure was shown to lower NAD lev-
els in two systems: isolated, human peripheral blood
lymphocytes (PBLs) [6], and human skin grafted to
nude mice [7]. The loss of NAD was partially pro-
tected by selective inhibitors of PARP [8]. According
to Berger’s hypothesis, decreased cellular NAD levels
should lead to decreased ATP levels. Exposure of
human PBLs to HD was indeed found to lower the
amounts of extractable ATP and, furthermore, pre-
treatment with PARP inhibitors conferred some pro-
tection against the ATP loss [9]. HD exposure also
initiated a concentration-dependent decrease in PBL
viability [10]. Pre-treatment of cells with PARP in-
hibitors, before exposure to HD, preserved viability
to an extent that correlated closely (r = 0.94) with the
IC50 values for PARP inhibition in vitro [11].
A systematic survey of cellular polypeptides from
PBLs exposed to HD revealed increased solubility of
core histones H3 and H2B after HD exposure. The
amino-terminus of H2B had been removed, perhaps
by a chymotrypsin-like protease [12]. Cells with al-
tered histone solubility also showed extensive DNA
fragmentation [12].
The goals of the present study were: (1) to char-
acterize the time and concentration dependence of
HD-initiated DNA fragmentation in human PBLs;
and (2) to examine whether DNA damage can be
mitigated by treatment with the selective PARP in-
hibitors that have been shown previously to protect
against metabolic injury.
2. Materials and methods
2.1. Materials
Reagents for making bu¡ers were purchased from
Fisher Scienti¢c Co., Pittsburgh, PA. Garamycin and
RPMI 1640 medium with L-glutamine, 25 mM
HEPES without sodium bicarbonate (RPMI
1640M) were purchased from Whittaker M.A. Bio-
products, Walkersville, MD. Percoll was purchased
from Pharmacia, Piscataway, NJ. Trypan blue,
propidium iodide (PI), niacinamide, niacin, 3-amino-
benzamide, and reagents for preparing agarose gels
were purchased from Sigma, St. Louis, MO. The
PARP inhibitors 3,4-dihydro-5-3-(methylamino)-
propoxy-1-(2H)-isoquinolinone, monohydrochloride
(ICD 2250) and 3,4-dihydro-5-methyl-1-(2H)-isoqui-
nolinone (ICD 2163) were gifts from Parke Davis. A
Beckman 70 pH meter, Becton Dickinson FACSort,
and Bio-Rad horizontal gel system were used to de-
termine pH, cellular £uorescence, and DNA patterns
respectively. Sulfur mustard and Lewisite were ob-
tained from the Chemical Research, Development,
and Engineering Center, Aberdeen Proving Ground,
MD and were determined to be s 99% pure by gas
chromatography.
2.2. Isolation of human PBLs
Blood (200 ml) was drawn from healthy, young
human volunteers (age range 19^46 years, seven
males and three females) under an approved human
use protocol. PBLs were isolated from blood by cen-
trifugation on a Percoll gradient (density = 1.080 at
20‡C) as described previously [13,14]. Cells were
washed twice with calcium-, magnesium-free Ty-
rode’s bu¡er, and once with RPMI containing gara-
mycin. Between washes, the cells were centrifuged at
900Ug for 10 min at 20‡C. The number of PBLs
obtained was determined by counting with a hema-
tocytometer. Cells were re-suspended in an appropri-
ate volume of RPMI 1640M medium and allocated
into tissue culture plates.
2.3. Exposure of cells to HD or Lewisite
Exposure was performed in serum-free RPMI
1640M medium using ¢nal concentrations of HD
ranging from 1036 to 1033 M, as described [10^12].
To ensure safety from highly toxic HD vapors, all
work with HD was conducted in a Class II, Type B2
tissue culture hood (Baker Company, Sanford, ME)
¢tted with a ¢ve train ¢lter system containing two
HEPA and three HEGA ¢lters. The cells were main-
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tained in a humidi¢ed CO2 incubator at 37‡C for the
indicated post-exposure time interval. For time
course experiments, cells were exposed to 3U1034
M HD at time zero and aliquots of exposed cells
were analyzed at 2, 4, 8, 12, 16, 20, or 24 h after
exposure.
For comparison, PBLs were exposed to HD
(3U1034 M), Lewisite (3U1034 M), or heat (55‡C
for 30 min) and genomic DNA patterns were com-
pared 24 h later. Lewisite was chosen because it is a
vesicating agent, which is more cytotoxic than HD,
but it is not known to alkylate DNA.
2.4. HD and PARP inhibitors
Cells were combined with RPMI 1640M medium
and PARP inhibitor 15 min before adding the appro-
priate volume of HD. Each experiment consisted of
four groups: (1) PBLs exposed to RPMI 1640M
alone; (2) PBLs exposed to RPMI 1640M with
HD; (3) PBLs exposed to RPMI 1640M with
PARP inhibitor; or (4) PBLs equilibrated for
15 min with RPMI 1640M containing PARP inhib-
itor and then exposed to HD. DNA was extracted at
either 2, 4, 6, 12, 16, 20, or 24 h after HD exposure
and analyzed by gel electrophoresis.
In some experiments, PARP inhibitor was added
to cell medium at either 1 h before, or at 1, 2, 4, 8,
12, 16, or 24 h after exposure to 3U1034 M HD.
Cells were incubated with HD for a total of 24 h
before analysis.
2.5. Determination of PBL viability
Cell viability was de¢ned operationally as the abil-
ity of PBLs to exclude PI. Freshly isolated PBLs
were placed in 200 Wl volumes at 1U106 cells/ml
for viability experiments. After treatment, cells were
removed from each well, incubated 3^5 min at room
temperature with 50 Wl of PI (50 mg/ml), and assayed
for £uorescent PI staining using a Becton Dickinson
FACSort and the accompanying Lysis software
[11,14]. At least 10 000 cells were assayed for each
sample in each analysis.
2.6. DNA extraction and electrophoresis
DNA analysis experiments were done using from
1^1.5U107 cells/well (24 well tissue culture plates) in
a total volume of 1 ml. Cells were transferred to
15 ml conical tubes by rinsing tissue culture plates
thrice in physiological saline, pH 7.5. Total genomic
DNA was puri¢ed by sequential applications of
protease K, RNAse, and a di¡erential salt extrac-
tion protocol. DNA was precipitated overnight
with ethanol at 310‡C (Gnome Kit, Bio 101, La
Jolla, CA).
Solubilized DNA in TE bu¡er was evaluated by
electrophoresis using 1^3% (w/v) agarose gels as de-
scribed [12]. The high concentration of agarose (3%
w/v) was used to detect oligonucleosome-sized DNA
fragments. DNA from approximately 106 cell equiv-
Fig. 1. Electrophoresis (2.5% agarose gel) of total genomic
DNA extracted from human PBLs. Each lane contains 1U106
cell equivalents of DNA extracted from cells which were main-
tained at 37‡C in a humidi¢ed CO2 incubator for 24 h after the
indicated treatment. Lane 1 contains DNA from control PBLs
(CONT); lane 2 contains DNA from PBLs exposed to 3U1034
M Lewisite (L); lane 3 contains DNA from PBLs killed by
heating at 55‡C for 30 min (Heat CONT); lane 4 contains
DNA from human PBLs exposed to 3U1034 M HD and subse-
quently heated at 55‡C for 30 min (Heat HD); and lane 5 con-
tains DNA from human lymphocytes exposed to 3U1034 M
HD. The percent viability for cell populations used to obtain
DNA for lanes 1^5 was: 98, 33, 59, 60 and 62%, respectively,
as measured by £ow cytometry using propidium iodide exclu-
sion with a standard deviation of less than 1%.
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alents was loaded into each gel lane and electropho-
resis was performed by application of constant volt-
age (100 V across 10 cm gels) at 10‡C.
3. Results
3.1. HD exposure causes DNA fragmentation
DNA fragmentation was de¢ned as: (1) smaller
average size of genomic DNA, as judged by the dis-
tance that DNA migrated into 2^3% (w/v) agarose
gels and (2) qualitative widening of the DNA band,
relative to DNA from control cells. Exposure to HD
consistently resulted in decreased cell viability and
extensive DNA fragmentation, relative to control
populations of cells from the same donor (Fig. 1).
Heating the PBLs to 55‡C for 30 min before expo-
sure to HD (3U1034 M), followed by incubation at
37‡C for 24 h, resulted in approximately the same
loss of viability (53% cell viability) only slightly al-
tered the HD-initiated DNA fragmentation.
The e¡ects of HD on genomic DNA were not
simply due to cytotoxicity. Heating PBLs to 55‡C
for 30 min, in the absence of HD, resulted in a sig-
ni¢cant reduction in cell viability at 24 h (59% viable
at 24 h), but had no e¡ect on the DNA pattern
observed on agarose gels (Fig. 1). Lewisite, a potent
vesicating agent, was more cytotoxic (34% of PBLs
viable at 24 h) than either HD or heating cells to
55‡C. However, genomic DNA extracted from Lew-
isite-exposed cells was indistinguishable by agarose
gel electrophoresis from DNA extracted from control
cells.
Fig. 2. E¡ect of increasing HD concentration on DNA from human lymphocytes. Lanes 1 and 12 contain DNA extracted from con-
trol PBLs that were exposed only to medium (CON). Lanes 2^11 contain DNA from PBLs of the same donor that were exposed to
HD at applied concentrations of: 1033, 6U1034, 3U1034, 1034, 6U1035, 3U1035, 1035, 6U1036, 3U1036, or 1036 M HD, respec-
tively.
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3.2. E¡ect of HD concentration
DNA fragmentation patterns depended upon the
concentration of HD (Fig. 2). Changes in the DNA
patterns were observed at 24 h after exposure to HD
concentrations as low as 6U1036 M (Fig. 2). As the
HD concentration was increased, the average size of
extracted DNA fragments apparently decreased, as
judged by migration distance of the center of mass
of the DNA bands in agarose gels. At the highest
HD concentrations used (1033 M), genomic DNA
was converted to a heterogeneous population of frag-
ments that migrated farther into 3% agarose gels
than did control DNA from the same donor (Fig. 2).
We found gel electrophoresis to be a sensitive and
reproducible method for detecting HD-induced frag-
mentation. Qualitative DNA changes were routinely
detected using as few as 106 cell equivalents. The
assay was sensitive to changes caused by HD concen-
trations as low as 6U1036 M HD at 24 h after ex-
posure.
3.3. E¡ect of post-exposure time interval
There was no appreciable loss of viability in the
control cells during the entire 24 h period studied. In
contrast, the viability of cells exposed to HD was
signi¢cantly decreased as early as 8 h after exposure,
and continued to decline over the 24 h incubation
period (Fig. 3). When DNA from control cells was
examined on 1.5% agarose gels, there also was no
change during the 24 h post-exposure interval.
Exposure to 3U1034 M HD, however, caused
DNA fragmentation as early as 2 h after exposure
(Fig. 4).
DNA fragmentation increased during the ¢rst 12 h
after HD exposure, manifesting as a thin ‘tail’ of
DNA that migrated progressively farther in agarose
gels. The DNA tail consisted of an oligonucleosome-
sized ‘ladder’ of decreasing size. Beginning at 6^16 h
Fig. 3. Post-exposure time dependence of HD-initiated cytotox-
icity. The number of damaged cells was assessed by PI incorpo-
ration into the cell nucleus. Human PBLs were exposed to
3U1034 M HD at time zero. At the indicated post-exposure
times, cells were removed from the 37‡C incubator and treated
with PI for 3 min at room temperature. For each result shown,
104 cells were examined individually on a FACSort to deter-
mine the percentage PI-positive cells.
Fig. 4. Post-exposure time dependence of HD-initiated DNA
fragmentation. Human PBLs were exposed to 3U1034 M HD.
At the indicated times after exposure, cells were removed from
the 37‡C incubator and the genomic DNA was extracted. Lane
1 contains DNA from control cells at time zero and lane 9 con-
tains DNA from control cells after a 24 h incubation. Lanes 2^
8 contain DNA extracted from cells at 2, 4, 6, 12, 16, 20 or 24
h after exposure, respectively.
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after exposure, depending on the applied concentra-
tion of HD, the DNA fragmentation pattern
changed. The DNA tail, which was lengthening dur-
ing the ¢rst 12 h after exposure, began to decrease in
length and the ladder pattern disappeared. By 24 h
after HD exposure, the ladder pattern was no longer
detectable and the DNA migrated as a heterogeneous
band with a center of mass apparently smaller than
control DNA from the same donor (Fig. 4).
3.4. E¡ect of PARP inhibitors on DNA fragmentation
Cells incubated in medium alone, or in medium
with only PARP inhibitors, showed a single narrow
band of DNA that migrated a similar distance in the
agarose gel for all time points studied (Fig. 5). Pre-
treatment of cells with PARP inhibitors, in contrast,
altered the HD-initiated DNA fragmentation pat-
tern. Cells treated with the most potent PARP inhib-
itors, ICD 2163 or ICD 2250, in combination with
HD, consistently showed a pronounced ‘tailing’ of
DNA that included a discrete, oligonucleosome-sized
DNA ladder pattern for the entire 24 h post-expo-
sure interval (Fig. 5).
3.5. E¡ect of PARP inhibitors depended on time of
addition
The PARP inhibitors preserved the DNA ladder
pattern only if added either 1 h before HD, or during
the ¢rst 2 h after HD. If inhibitors were added 4 h
after HD, the DNA ladder remained detectable, but
was superimposed with heterogeneous DNA band.
By 8 h after HD exposure, addition of the PARP
inhibitors had no detectable e¡ect (Fig. 6). Protec-
tion of viability by PARP inhibitor addition in PBLs
exposed to HD also decreased as the time of addition
was delayed, as reported previously [14].
Fig. 5. E¡ect of PARP inhibitors on genomic DNA fragmentation as a function of the post-exposure time interval. For each time
point, given in hours at the top of the gel, there are four lanes that contain DNA from cells treated as follows (left to right): (1) me-
dium alone (controls); (2) 3U1034 M HD; (3) 3U1034 M HD+3U1034 M PARP inhibitor; (4) 3U1034 M PARP inhibitor alone.
Beginning at 4 h after HD exposure, the PBL DNA showed detectable fragmentation. Initially, DNA extracted from cells treated
with HD alone showed a ‘ladder pattern’ of discrete, oligonucleosome-sized DNA fragments, characteristic of apoptotic cell death. At
approximately 16 h after exposure, the pattern changed qualitatively. The DNA migrated as a heterogeneous, ‘broad band’ of frag-
ments smaller than DNA extracted from control cells or cells treated only with PARP inhibitors. In contrast, the cells exposed to HD
in the presence of a PARP inhibitor retained the ‘ladder’ con¢guration over the entire 24 h post-exposure period. Identical results
were obtained using ICD 2250 or ICD 2163 as the PARP inhibitor.
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4. Discussion
4.1. HD exposure causes genomic DNA
fragmentation
We previously reported that exposure of human
PBL preparations to HD causes time- and concen-
tration-dependent decreases in viability [10], NAD
levels [8], and ATP levels [9], as well as qualitative
alterations in core histones and genomic DNA [12].
The present study found that fragmentation of nu-
clear DNA, as judged by gel electrophoresis, also
depended upon the HD concentration and the post-
exposure time interval.
Changes in gel electrophoresis patterns were nei-
ther artifacts of DNA extraction, nor the result of
non-speci¢c cytotoxicity, because DNA fragmenta-
tion was not observed in PBLs that were killed
with heat or Lewisite (Fig. 1). HD-initiated DNA
fragmentation was only slightly altered by heating
the cells to 55‡C for 30 min before exposure (Fig.
1). This suggested that fragmentation was not solely
dependent upon the activity of heat-labile DNases.
DNA strand breaks probably resulted from direct
interaction of the HD on the genome, including al-
kylation [3] and disruption of the histone-DNA core
particle [12].
While studying the e¡ects of HD concentration
and the post-exposure time interval, we found evi-
dence for at least two distinct types of DNA frag-
mentation. There was an initial type of fragmenta-
tion caused by HD exposure that resulted in a DNA
ladder pattern identical to that reported to occur
during apoptotic cell death [15]. With increased
time after exposure, however, the ladder pattern dis-
appeared and a wider band of DNA was observed
with a tail pattern similar to that seen in necrotic cell
death [15]. The conversion of the dominant type of
DNA fragmentation from a ladder to the wide band
occurred 6^16 h after HD exposure, depending on
the applied concentration of HD. DNA fragmenta-
tion and time of conversion occurred earlier after
exposure to higher HD concentrations. The delayed
conversion from apoptotic to necrotic DNA frag-
mentation was consistent with earlier reports of a
concentration-dependent latent period of 6^16 h
after HD exposure, during which the cell membrane
remains functional and the cells are capable of oper-
ating metabolic pathways [10,14,16].
4.2. Mitigation of HD e¡ects by PARP inhibitors
Treatment of PBLs with PARP inhibitors was
shown previously to reduce the membrane damage
caused by HD exposure [17]. Likewise, the PARP
inhibitors could partially block HD-initiated de-
creases in cell viability [10], NAD levels [6], and
ATP levels [9]. The degree of protection was propor-
tional to the ability of the compound to inhibit
PARP in vitro [11]. The most potent PARP inhibi-
tors tested, ICD 2163 and 2250, almost completely
blocked the HD-induced changes in viability [11,14]
and metabolism caused by HD [8,9].
In contrast with metabolic protection, the PARP
inhibitors were unable to prevent DNA fragmenta-
tion in cells exposed to HD (Fig. 5). The inhibitors
were able, however, to alter the fragmentation pat-
terns. Addition of PARP inhibitors to the cell me-
dium blocked the time-dependent conversion of
DNA fragmentation from the initially dominant lad-
Fig. 6. Maintenance of the ‘DNA ladder’ depends upon the
time of PARP addition. PBLs were exposed to 3U1034 M HD.
The PARP inhibitor, ICD 2250, was added at the indicated
post-exposure times, and cells were then incubated for a total
of 24 h. As shown in Fig. 5, pretreatment (31 h) or immediate
addition (0 h) of the PARP inhibitor after HD exposure re-
sulted in a ‘DNA ladder’ pattern of fragmentation. However, if
the PARP inhibitor was added later than 8 h after HD, it failed
to arrest DNA fragmentation at the ladder stage. Identical re-
sults were obtained using ICD 2163 under the same conditions.
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der pattern to the later dominant wide band DNA
pattern (Fig. 5). Thus, it appeared that the PARP
inhibitors changed the kinetics of DNA cleavage so
that the cell death remained apoptotic during the
entire 24 h post-exposure time interval.
The mechanism by which the PARP inhibitors ar-
rest cells at the stage of a DNA ladder is unknown,
but it could involve preservation of condensed chro-
matin. Histones have been linked to pADP-RP by a
‘histone shuttle mechanism’ of DNA repair [18]. In-
hibition of pADP-RP e¡ectively blocks this mecha-
nism in HD-treated PBLs. This would prevent the
cell from unwinding the core particle for repair,
thereby resulting in the oligonucleosome-sized
‘DNA ladder’ fragments observed. In contrast, un-
protected cells would be expected to show a hetero-
geneous distribution of smaller fragments because
pADP-RP activation removes histones and exposes
more DNA for HD alkylation and subsequent strand
breakage.
The PARP inhibitors were only e¡ective at pre-
venting the conversion from an apoptotic-like DNA
fragmentation pattern to a necrotic-like DNA frag-
mentation pattern if added within 8 h of HD expo-
sure. This paralleled the time course reported for
protection of the HD-initiated decrease in membrane
function [10,14]. The PARP inhibitors were able to
preserve some metabolic pathways when added in a
delayed treatment mode. The relationship between
metabolic and nuclear e¡ects of the PARP inhibitors
is unknown, but both e¡ects apparently involved cel-
lular events that occur during the ¢rst several hours
after exposure to a cytotoxic concentration of HD.
4.3. Therapeutic switch from necrosis to apoptosis?
The PARP inhibitors may exert an overall bene¢-
cial e¡ect by reducing the normal cellular response to
extensive DNA alkylation. As predicted by Berger,
inhibition of repair processes that require PARP
would be expected to preserve cellular energy levels
and, thereby, to slow loss of metabolic function and
disruption of the cell membrane [4].
‘Knock-out’ mice that completely lack PARP ac-
tivity (PARP3/3) were shown to develop structur-
ally normal skin that forms an intact barrier [19].
However, cells from PARP3/3 mice showed im-
paired proliferation [19] and faulty DNA repair
mechanisms [20] when exposed to the stress of
DNA damaging agents. Other in vitro or ex vivo
model systems have shown that reduction of PARP
activity impairs normal cellular responses to DNA
damaging agents, perhaps in a cell cycle-dependent
manner [21^23]. Our results with HD suggest that
impaired proliferation and DNA repair in PARP-de-
¢cient cells may result from a greater fraction of
damaged cells arrested in a metabolically active but
apoptotic state, perhaps because chromatin can not
be opened e⁄ciently for DNA repair.
The ability of PARP inhibitors to alter the cyto-
toxic mechanism of DNA alkylating agents was dem-
onstrated in human cells by studying metabolic and
DNA changes induced by the inhibitors [24]. It ap-
peared that SM exposure activated an early apop-
totic-like mechanism of cell death. In the absence
of PARP inhibitors, this apoptotic mechanism was
replaced with a necrotic mechanism at 4^8 h after
SM exposure. The presence of inhibitors of PARP
in the culture medium either prevented the necrotic
mechanism or limited it to a minor role in the death
of the cell.
Our initial results with SM-mediated cell death can
be compared with the mechanism of HT-29 cell
death initiated by H2O2, another DNA damaging
cytotoxic agent [25]. The H2O2-initiated HT-29 cell
death was found to occur by an immediate necrotic-
type cell death mechanism, followed by a delayed
apoptotic mechanism. Although PARP inhibitors
were able to block the immediate necrotic pathway,
the delayed apoptotic pathway was nevertheless acti-
vated. It was concluded that the delayed pathway
caused cell death and the eventual detachment of
the HT-29 cells from the tissue culture plates [25].
The experiments presented in this article support
our conclusion that the initial mechanism of SM cy-
totoxicity was the activation of an apoptotic-like
pathway. However, in contrast with H2O2, exposure
to SM resulted in a latent necrotic cytotoxicity that
was manifest only when metabolic cofactors had
been reduced to a level of about 50% of control
cells.
The role of PARP in DNA damage-mediated cell
death initiated by H2O2 in a motor neuron cell line
has also been investigated [26]. PARP activation oc-
curred in this in vitro model, and the introduction of
PARP inhibitors blocked an increased immunologic
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staining of poly(ADP-ribose) polymers. Although the
mechanism of cell death was not de¢ned, the authors
were able to conclude that signi¢cant DNA fragmen-
tation occurred both in the presence and absence of
PARP inhibitors. The e¡ectiveness of PARP inhibi-
tors in altering the mechanism of DNA damage-
mediated cell death was subsequently demonstrated
in whole animal experiments [27].
Using an ischemia-induced cell model in vivo,
moderate concentrations of PARP inhibitors were
shown to reduce the infarction volume damage fol-
lowing reperfusion in male Wistar rats with experi-
mentally produced middle cerebral artery occlusion
[27]. PARP inhibitors e¡ectively prevented or re-
duced cytotoxicity initiated by DNA damaging
agents in both in vitro and in vivo experiments.
However, the order of the activation of the di¡erent
mechanisms of cell death (apoptosis and necrosis)
was not resolved. To determine treatment regimens
and limiting treatment schedules for tissue exposed
to DNA damaging conditions, the kinetics of cell
death mechanism(s) should be extensively investi-
gated.
We speculate that the PARP inhibitors may have
therapeutic utility at preventing or reducing the le-
sion initiated by HD exposure if they promote a non-
proliferative, apoptotic state in basal keratinocytes of
HD-exposed skin. Although PARP inhibition im-
pairs suicide DNA repair function, it does not ap-
pear to a¡ect normal functions at the cellular and
tissue level. The inhibition of the necrotic suicidal
repair mechanism should result in the amelioration
of the overall tissue injury. Unlike the necrotic re-
sponse to HD alone, the PARP inhibitors favor an
apoptotic state, which appears to be the normal ma-
turation mechanism of keratinocytes in skin. Thus
with the HD-DNA damaged cells in a normal apop-
totic state the cells may be passed to the stratum
corneum where they are eliminated or these cells
may be reabsorbed as occurs in other tissues where
apoptotic cell death takes place. In either case, the
dying cells would be eliminated instead of rapidly
lysing to release pro-in£ammatory components and
lysosomal proteases as seen in necrotic cell death.
Meaningful tests of this hypothesis, as well as eval-
uation of PARP inhibitors as therapeutic anti-vesi-
cants, await development of suitable animal models
for intact human skin.
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